Improving participation of Hispanic children in cancer clinical trials
Official title: Multisite Implementation of COMPRENDO (ChildhOod Malignancy Peer REsearch NavigatiOn) to improve participation of Hispanic children in cancer clinical trials
Funded at University of California, San Diego · NIH-10894170 · Data updated 2026-11-12
This study is all about helping Hispanic families with children who have cancer by providing support from trained parents, so they can better understand and feel comfortable joining clinical trials that could help improve their child's care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | July 26, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $634,874 |
| NIH project number | 5R01CA279945-02 |
| Project ID | NIH-10894170 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Hispanic children diagnosed with cancer and their parents or guardians.
✕Less likely to help
Patients who are not Hispanic or do not have a cancer diagnosis may not receive benefit from this research.
What this research studies
This research aims to enhance the participation of Hispanic children in cancer clinical trials by implementing a peer navigation program called COMPRENDO. The program involves trained parents who provide culturally and linguistically appropriate education to other parents and guardians of children with cancer. By addressing barriers such as inadequate research literacy, the project seeks to improve understanding and decision-making regarding clinical trial participation. The initiative is crucial as it targets a demographic that is currently underrepresented in clinical trials, thereby aiming to reduce disparities in cancer outcomes.
Why it matters
Potential benefit: If successful, this research could lead to increased enrollment of Hispanic children in cancer clinical trials, ultimately improving their survival rates and health outcomes.
How similar studies have gone: Previous research has shown success with peer navigation models in improving clinical trial participation among underrepresented populations, indicating a promising approach.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Aristizabal, Paula — University of California, San Diego
- Study coordinator: Aristizabal, Paula
Related research
Other NIH-funded projects on the same topics.
-
Detecting cancer risk and treatment response in NF1 nerve tumors using cfDNA markers
A doctor-led study will test blood-based DNA markers to detect when NF1-related nerve tumors become malignant and to monitor how well treatment is working.
-
Epigenetic Basis for Controlling Aggressive IDH-Mutant Gliomas
Aims to understand and shape the epigenetic changes in IDH-mutant brain tumors to restrain their growth, which could lead to new, targeted treatment options for patients.
-
US–East Africa center to prevent and detect virus-linked cancers in people with HIV
This program builds a US–East Africa research network to train local investigators and improve prevention, earlier detection, and faster connection to care for virus-related cancers in people with HIV.
-
U.S.–East Africa program to prevent, detect early, and link people with HIV-related cancers to care
This program brings U.S. and East African teams together to help people with HIV by improving prevention, earlier detection, and faster connection to care for cancers linked to the virus.
-
U.S.–East Africa center to prevent and find HIV-related cancers and speed connection to care
This program builds a U.S.–East Africa team to improve prevention, earlier detection, and faster linkage to care for people with HIV at risk for cervical cancer and Kaposi’s sarcoma.
-
Boosting TET Activity to Help Treat AML with Vitamin C
Vitamin C may help people with a type of blood cancer (AML) by boosting a natural anti-cancer pathway, potentially improving outcomes for adults with this disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.